Merck & Co Inc (FRA:6MK)
€ 92.9 -0.2 (-0.21%) Market Cap: 236.96 Bil Enterprise Value: 261.27 Bil PE Ratio: 21.36 PB Ratio: 5.93 GF Score: 78/100

Merck & Co Inc Annual Shareholders Meeting Transcript

May 24, 2022 / 01:00PM GMT
Release Date Price: €87.6 (-1.13%)
Operator

At this time, please welcome Merck's Executive Chairman, Kenneth Frazier.

Kenneth C. Frazier
Merck & Co., Inc. - Executive Chairman

Thank you, and good morning, everyone. It's my pleasure to welcome you all to the 2022 Annual Meeting of Shareholders and to call this meeting to order. We've adopted a solely virtual format for this meeting to provide a safe, consistent and convenient experience to all shareholders regardless of their locations. I look forward to our time together and I hope you're all safe and well.

I'd like to acknowledge that all of our directors and director nominees nominated for election at this meeting are also attending virtually. In addition to the business portion of the meeting, Rob Davis, Chief Executive Officer and President of Merck, will provide an update on Merck over the past year. And then Dr. Dean Li, Executive Vice President and President of Merck Research Laboratories, will talk about our efforts to accelerate and advance our broad pipeline and where we are making important investments in our research activities

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot